Australia markets closed

Alterity Therapeutics Limited (ATH.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.00500.0000 (0.00%)
At close: 04:10PM AEST
Currency in AUD

Valuation measures4

Market cap (intra-day) 26.19M
Enterprise value 10.63M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)735.64
Price/book (mrq)1.15
Enterprise value/revenue -1.77k
Enterprise value/EBITDA 1.13

Trading information

Stock price history

Beta (5Y monthly) 0.72
52-week change 3-16.67%
S&P500 52-week change 326.14%
52-week high 30.0085
52-week low 30.0030
50-day moving average 30.0052
200-day moving average 30.0057

Share statistics

Avg vol (3-month) 311.07M
Avg vol (10-day) 31.58M
Shares outstanding 55.24B
Implied shares outstanding 66.29B
Float 82.54B
% held by insiders 17.26%
% held by institutions 13.50%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 June 2023
Most-recent quarter (mrq)31 Dec 2023


Profit margin 0.00%
Operating margin (ttm)-348.40%

Management effectiveness

Return on assets (ttm)-28.94%
Return on equity (ttm)-53.72%

Income statement

Revenue (ttm)3.43M
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)-20.30%
Gross profit (ttm)N/A
EBITDA -12.83M
Net income avi to common (ttm)-12.28M
Diluted EPS (ttm)-0.0000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)12.32M
Total cash per share (mrq)0
Total debt (mrq)255.6k
Total debt/equity (mrq)1.45%
Current ratio (mrq)4.89
Book value per share (mrq)0.01

Cash flow statement

Operating cash flow (ttm)-14.61M
Levered free cash flow (ttm)-9.95M